HealthTree Podcast for Multiple Myeloma: Dr. Sergio Giralt, MSKCC

HealthTree Podcast for Multiple Myeloma: Dr. Sergio Giralt, MSKCC

46:06 |

Related Videos

Setting Up Your Expectations For Having Myeloma

Setting Up Your Expectations For Having Myeloma

Overview of HealthTree Programs for Multiple Myeloma

Overview of HealthTree Programs for Multiple Myeloma

How Personalized Is Myeloma Treatment and How Is Changing? Introducing the Individual Risk Model

How Personalized Is Myeloma Treatment and How Is Changing? Introducing the Individual Risk Model

The Current Standard of Care in the Post-Transplant Setting | Fredrik Schjesvold, MD, PhD | IMS 2024

The Current Standard of Care in the Post-Transplant Setting | Fredrik Schjesvold, MD, PhD | IMS 2024

HealthTree Study: Dexamethasone's Impact on Eye Health in Myeloma | Rahul Banerjee, MD | IMS 2024

HealthTree Study: Dexamethasone's Impact on Eye Health in Myeloma | Rahul Banerjee, MD | IMS 2024

HealthTree Podcast for Multiple Myeloma: Dr. Rodger Tiedemann, UHN

HealthTree Podcast for Multiple Myeloma: Dr. Rodger Tiedemann, UHN

The Future of Myeloma Drug Development | Dickran Kazandjian, MD

The Future of Myeloma Drug Development | Dickran Kazandjian, MD

Talquetamab in Myeloma: Results from HealthTree Qualitative Research | Beth Faiman | #ASH24

Talquetamab in Myeloma: Results from HealthTree Qualitative Research | Beth Faiman | #ASH24

$DREAMM‑3 - Blenrep (Belmaf) Vs PomDex For Relapsed/Refractory Myeloma | Katja Weisel, MD | ASCO 2023$

DREAMM‑3 - Blenrep (Belmaf) Vs PomDex For Relapsed/Refractory Myeloma | Katja Weisel, MD | ASCO 2023

An Introduction to HealthTree for Multiple Myeloma

An Introduction to HealthTree for Multiple Myeloma

CAR-T Therapy, CARTITUDE-1 ciltacabtagene autoleucel in RRMM Patients | Yi Lin, MD, PhD | ASCO 2023

CAR-T Therapy, CARTITUDE-1 ciltacabtagene autoleucel in RRMM Patients | Yi Lin, MD, PhD | ASCO 2023

Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023

Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023

Real Cancer Stories: Janet Schurmann

Real Cancer Stories: Janet Schurmann

Know Your Myeloma Therapy: What's Available for Maintenance Therapy?

Know Your Myeloma Therapy: What's Available for Maintenance Therapy?

Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research

Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research

Results of Bispecific Antibody Combination in Advanced Myeloma | Yael Cohen, MD | ASCO 2023

Results of Bispecific Antibody Combination in Advanced Myeloma | Yael Cohen, MD | ASCO 2023

HealthTree Podcast for Multiple Myeloma: Dr.Frits van Rhee, UAMS

HealthTree Podcast for Multiple Myeloma: Dr.Frits van Rhee, UAMS

Is MRD Negativity the Goal of Myeloma Treatment?

Is MRD Negativity the Goal of Myeloma Treatment?

Salt Lake Round Table - HealthTree Foundation for Multiple Myeloma

Salt Lake Round Table - HealthTree Foundation for Multiple Myeloma

© 2024 Tubidy